{
    "eid": "2-s2.0-85081614904",
    "title": "In major depression, increased kappa and mu opioid receptor levels are associated with immune activation",
    "cover-date": "2020-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Biological Psychiatry",
            "@code": "2803",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "cytokines",
        "depression",
        "endorphin",
        "neuro-immune",
        "opioid receptor"
    ],
    "authors": [
        "Hussein Kadhem Al-Hakeim",
        "Suhaer Zeki Al-Fadhel",
        "Arafat Hussein Al-Dujaili",
        "Michael Maes"
    ],
    "citedby-count": 12,
    "ref-count": 85,
    "ref-list": [
        "IL-10 is associated with increased mu-opioid receptor levels in major depressive disorder",
        "Serum cortisol, immunoglobulins and some complements among depressed patients",
        "Al-DujailiAH and MaesM(2018a) Serum interleukin levels and insulin resistance in major depressive disorder",
        "IL-6, IL-18, sIL-2R, and TNF proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation",
        "Reduction in serum IL-1 IL-6 and IL-18 levels and Beck Depression Inventory-II score by combined sertraline and ketoprofen administration in major depressive disorder: A clinical trial",
        "Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50, 488H",
        "Targeting opioid receptor signalling in depression: Do we need selective kappa opioid receptor antagonists",
        "An update on neural regulators of the hypothalamic-pituitary-adrenal axis",
        "Statistics review 13: Receiver operating characteristic curves",
        "Opioid receptors and signaling on cells from the immune system",
        "Control of hormonal stress reactivity by the endogenous opioid system",
        "The dynorphin-kappa opioid system as a modulator of stress-induced and pro-addictive Behaviors",
        "Biological substrates of reward and aversion: A nucleus accumbens activity hypothesis",
        "Monocytic dysfunction by opioid peptides in patients with major depression",
        "Inflammation, serotonin and major depression",
        "Plasma beta-endorphin and natural killer cell activity in major depression: A preliminary study",
        "Role of dopamine in the behavioural actions of nicotine related to addiction",
        "IncreasedmRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims",
        "Dissociation between CSF and plasma B-endorphin in major depressive disorders: Evidence for a different regulation",
        "Prodynorphin gene disruption increases the sensitivity to nicotine selfadministration in mice",
        "The role of anxious distress in immune dysregulation in patients with major depressive disorder",
        "Inhibition of T cell super antigen responses following treatment with the kappa-opioid agonist U50, 488H",
        "Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder",
        "Kappa-opioid receptor modulation of nicotine-induced behaviour",
        "Subjects with major depression or bipolar disorder show reduction of prodynorphin mRNA expression in discrete nuclei of the amygdaloid complex",
        "Retrograde opioid signaling regulates glutamatergic transmission in the hypothalamus",
        "Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats",
        "Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum",
        "Kappa opioid receptor tolerance in the Guinea pig hippocampus",
        "Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women",
        "A potential role for proinflammatory cytokines in regulating synaptic plasticity in major depressive disorder",
        "Dynorphin, stress, and depression",
        "Peripheral cytokine and chemokine alterations in depression: A meta-analysis of 82 studies",
        "Depression: An inflammatory illness",
        "The kappa opioid receptor: From addiction to depression, and back",
        "The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system",
        "Reward processing by the opioid system in the brain",
        "Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression",
        "The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes",
        "Prevalence of depression in the community from 30 countries between 1994 and 2014",
        "Dendritic peptide release and peptide-dependent behaviours",
        "Opioid receptors: Distinct roles in mood disorders",
        "Different mechanisms of intrinsic pain inhibition in early and late inflammation",
        "A further exploration of the relationships between immune parameters and the HPA-axis activity in depressed patients",
        "The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder",
        "Adrenocorticotropin hormone, beta-endorphin and cortisol responses to oCRF in melancholic patients",
        "An augmented escape of beta-endorphins to suppression by dexamethasone in severely depressed patients",
        "A multivariate study of simultaneous escape from suppression by dexamethasone of urinary free cortisol, plasma cortisol, adrenocorticotropic hormone and beta-endorphin in melancholic patients",
        "Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats",
        "Kappa opioid receptor binding in major depression: A pilot study",
        "Regulation of human B lymphocyte activation by opioid peptide hormones. Inhibition of IgG production by opioid receptor class (mu-, kappa-, and delta-) selective agonists",
        "Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain",
        "Role of the mu opioid receptor in opioid modulation of immune function",
        "Opioid system and human emotions",
        "Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder",
        "Acomparison of inflammatory markers in depressed and nondepressed smokers",
        "The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence",
        "Association of paraoxonase (PON) 1 activity, glutathione S-transferase GST T1/M1 and STin 2 polymorphisms with comorbidity of tobacco use disorder and mood disorders",
        "Association between placebo-activated neural systems and antidepressant responses: Neurochemistry of placebo effects in major depression",
        "Endogenous opioid system dysregulation in depression: Implications for new therapeutic approaches",
        "Effects of the mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures",
        "Expectancy modulation of opioid neurotransmission",
        "Antiinflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation",
        "A multiple motives approach to tobacco dependence: The Wisconsin Inventory of Smoking Dependence Motives (WISDM-68",
        "Inflammation enhances mu-opioid receptor transcription and expression in mice intestine",
        "Endogenous opioids and smoking: A review of progress and problems",
        "Immunomodulatory effects of endogenous and synthetic peptides activating opioid receptors",
        "Association of plasma interleukin-18 levels with emotion regulation and -opioid neurotransmitter function in major depression and healthy volunteers",
        "Inhibitory effects of dynorphin 3-14 on the lipopolysaccharide-induced toll-like receptor 4 signalling pathway",
        "Subcellular targeting of kappa-opioid receptors in the rat nucleus locus coeruleus",
        "Dynorphin-containing axons directly innervate noradrenergic neurons in the rat nucleus locus coeruleus",
        "Pain and the immune system",
        "Leukocytes in the regulation of pain and analgesia",
        "30 years of dynorphins-new insights on their functions in neuropsychiatric diseases",
        "Targeting endogenous muand delta-opioid receptor systems for the treatment of drug addiction",
        "Immunology, signal transduction, and behavior in hypothalamic-pituitary-adrenal axis-related genetic mouse models",
        "Opiate receptors and beyond: 30 years of neural signaling research",
        "Attacking pain at its source: New perspectives on opioids",
        "Comparative immunocytochemical localization of putative opioid ligands in the central nervous system",
        "Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line:morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence",
        "Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids",
        "Kappa opioids, salvinorin A and major depressive disorder",
        "Regulation of the hypothalamic-pituitaryadrenal axis by cytokines: Actions and mechanisms of action",
        "A review of the relationship between proinflammatory cytokines and major depressive disorder"
    ],
    "affiliation": [
        {
            "affiliation-city": "Kufa",
            "@id": "60071160",
            "affilname": "University of Kufa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071160",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        }
    ],
    "funding": []
}